Journal ArticleJ Invest Dermatol · November 2024
Prurigo nodularis (PN) is a chronic, inflammatory skin condition that disproportionately affects African Americans and features intensely pruritic, hyperkeratotic nodules on the extremities and trunk. PN is understudied compared with other inflammatory ski ...
Full textLink to itemCite
Journal ArticleJAAD Int · September 2024
BACKGROUND: Chronic pruritus (CP) is a poorly characterized condition associated with intense pruritus without a primary skin eruption. This condition tends to emerge more commonly in older adults, and there is limited research on triggering factors. OBJEC ...
Full textLink to itemCite
Journal ArticleSci Rep · July 29, 2024
Chronic pruritus of unknown origin (CPUO) is characterized by chronic itch for 6 weeks or greater without an identifiable primary cause. Studies are needed to investigate circulating blood biomarkers to elucidate disease pathogenesis. The objective of this ...
Full textLink to itemCite
Journal ArticleJ Invest Dermatol · July 2024
Prurigo nodularis (PN) is an intensely pruritic, inflammatory skin disease with a poorly understood pathogenesis. We performed single-cell transcriptomic profiling of 28,695 lesional and nonlesional PN cells. Lesional PN has increased dysregulated fibrobla ...
Full textLink to itemCite
Journal ArticleJAMA Dermatol · July 1, 2024
IMPORTANCE: Prurigo nodularis (PN) and chronic pruritus of unknown origin (CPUO) are chronic pruritic diseases that dramatically impair quality of life, but therapeutic options are limited. Abrocitinib, a Janus kinase 1 inhibitor, represents a promising th ...
Full textLink to itemCite
Journal ArticleJID Innov · July 2024
Prurigo nodularis (PN) is a chronic inflammatory skin disease characterized by intense pruritus and skin nodules. Beyond the skin, PN involves circulating blood inflammation that may contribute to systemic disease comorbidities. Dupilumab was recently appr ...
Full textLink to itemCite
Journal ArticleSci Rep · April 6, 2024
Prurigo nodularis (PN) is a chronic inflammatory skin disease that is associated with variability in peripheral blood eosinophil levels and response to T-helper 2 targeted therapies (Th2). Our objective was to determine whether circulating immune profiles ...
Full textLink to itemCite
Journal ArticleSci Rep · January 23, 2024
Mycosis fungoides (MF) is the most common form of cutaneous T-cell lymphoma (CTCL). Despite having a wide variety of therapeutic agents available for the treatment of MF, patients often suffer from a significant decrease in quality of life and rarely achie ...
Full textLink to itemCite
Journal ArticleFront Immunol · 2024
IMPORTANCE: Disease models for atopic dermatitis (AD) have primarily focused on understanding underlying environmental, immunologic, and genetic etiologies. However, the role of metabolic mechanisms in AD remains understudied. OBJECTIVE: To investigate the ...
Full textLink to itemCite
Journal ArticleJ Invest Dermatol · December 2023
Prurigo nodularis (PN) is an understudied inflammatory skin disease characterized by pruritic, hyperkeratotic nodules. Identifying the genetic factors underlying PN could help to better understand its etiology and guide the development of therapies. In thi ...
Full textLink to itemCite
Journal ArticleJAMA Dermatol · September 1, 2023
IMPORTANCE: Prurigo nodularis (PN) is a debilitating skin disease characterized by intense pruritus and hyperkeratotic skin nodules. Nemolizumab, a monoclonal antibody targeting interleukin 31 receptor α, is a promising novel therapy for the treatment of m ...
Full textLink to itemCite
Journal ArticleJID Innov · July 2023
Actinic keratoses (AKs) are premalignant intraepidermal neoplasms that occur as a result of cumulative sun damage. AKs commonly relapse, and up to 16% undergo malignant transformation into cutaneous squamous cell carcinoma. There is a need for novel therap ...
Full textLink to itemCite
Journal ArticleInt J Mol Sci · April 29, 2023
Mycosis fungoides (MF) is the most common form of cutaneous T-cell lymphoma (CTCL) and is characterized by epidermotrophism of malignant CD4+ T-lymphocytes. When MF advances to a recurrent stage, patients require treatment with systemic therapies such as v ...
Full textLink to itemCite
Journal ArticleJID Innov · January 2023
UV irradiation is commonly used in murine models of skin cancers. Despite the popularity of using UVB rays to model photocarcinogenesis in animals, there is a lack of standardization in the secondary enclosures used to administer radiation. An appraisal of ...
Full textLink to itemCite
Journal ArticleJ Invest Dermatol · November 2022
Cutaneous immune-related adverse events (cirAEs) are the most prevalent complication to arise from immunotherapy and cause significant morbidity. We aimed to determine the spectrum, timing, clinical features, and outcomes of cirAEs by conducting an observa ...
Full textLink to itemCite
Journal ArticleJ Invest Dermatol · May 2022
Patients with prurigo nodularis (PN) suffer from intractable itch and dramatic reduction in QOL. Although there is significant clinical heterogeneity in the presentation of PN, disease endotypes remain unknown. We assayed circulating plasma cytokine concen ...
Full textLink to itemCite
Journal ArticleInt J Mol Sci · April 10, 2022
Epidermal Growth Factor Receptor (EGFR) is amplified in over 50% of glioblastomas and promotes tumor formation and progression. However, attempts to treat glioblastoma with EGFR tyrosine kinase inhibitors have been unsuccessful thus far. The current standa ...
Full textLink to itemCite
Journal ArticleFront Med (Lausanne) · 2022
Prurigo nodularis (PN) is a chronic, pruritic, inflammatory skin disease characterized by hyperkeratotic nodules on the trunk and extremities. While there is growing research on the immunological basis of PN, the neuropathic and structural components of PN ...
Full textLink to itemCite
Journal ArticleJ Invest Dermatol · September 2021
Prurigo nodularis (PN) is an understudied, chronic inflammatory skin disease that disproportionately affects African Americans and presents with intensely pruritic nodules of unknown etiology. To better characterize the immune dysregulation in PN, PBMCs an ...
Full textLink to itemCite
Journal ArticleClin Exp Dermatol · July 2021
Atopic dermatitis (AD) is chronic, pruritic, inflammatory skin disease that affects a significant portion of the population in industrialized nations. For nonresponders to conventional therapies, AD can significantly reduce sleep quality and quality of lif ...
Full textLink to itemCite
Journal ArticleDrugs · June 2021
Chronic pruritus is a debilitating symptom with limited treatment options. Identifying molecular targets underlying chronic pruritic dermatoses is essential for the development of novel, targeted therapies. IL-31 is an important mediator of itch by integra ...
Full textLink to itemCite
Journal ArticleSci Rep · May 27, 2021
Atopic dermatitis (AD) often presents more severely in African Americans (AAs) and with greater involvement of extensor areas. To investigate immune signatures of AD in AAs with moderate to severe pruritus, lesional and non-lesional punch biopsies were tak ...
Full textLink to itemCite
Journal ArticleJ Clin Med · February 6, 2021
The complexity of atopic dermatitis (AD) continues to present a challenge in the appropriate selection of a mouse model because no single murine model completely recapitulates all aspects of human AD. This has been further complicated by recent evidence of ...
Full textLink to itemCite
Journal ArticleJ Am Acad Dermatol · February 2021
BACKGROUND: Pruritus is a common symptom that can significantly reduce quality of life through sleep disruption. OBJECTIVE: To examine features of disturbed sleep in patients with chronic pruritic dermatoses and test the hypothesis that systemic inflammati ...
Full textLink to itemCite
Journal ArticleJ Pharmacol Toxicol Methods · 2021
Actinic keratoses (AKs) represent a premalignant skin condition due to chronic sun damage that dramatically increases in prevalence in the aging population. Currently, animal models of AKs utilize photocarcinogenesis, chemical carcinogens, or targeted gene ...
Full textLink to itemCite
Journal ArticleOncotarget · June 2, 2020
Epidermal Growth Factor Receptor variant III (EGFRvIII) is an active mutant form of EGFR that drives tumor growth in a subset of glioblastoma (GBM). It occurs in over 20% of GBMs, making it a promising receptor for small molecule targeted therapy. We hypot ...
Full textLink to itemCite
Journal ArticleMedicines (Basel) · January 8, 2020
Background: Prurigo nodularis (PN) is an intensely pruritic skin condition of considerable morbidity. However, the pathogenesis of PN and its association with underlying neuropathy is unclear. Objective: We sought to investigate the association between PN ...
Full textLink to itemCite
Journal ArticleMedicines (Basel) · December 9, 2019
Background: Epidermal growth factor receptor (EGFR) inhibitors can cause serious cutaneous toxicities, including pruritus and papulopustular acneiform skin eruptions. Increasingly, the neurokinin-1 receptor (NK1R) antagonist aprepitant is being utilized as ...
Full textLink to itemCite
Journal ArticleMedicines (Basel) · September 26, 2019
Prurigo nodularis (PN) is a chronic inflammatory skin disease characterized oftentimes by symmetrically distributed, severely pruritic nodules. Currently, the pathophysiology of PN remains to be fully elucidated, but emerging evidence suggests that neuroim ...
Full textLink to itemCite
Journal ArticleCurr Cancer Drug Targets · 2017
Glioblastoma (GBM) is a deadly brain cancer, and all attempts to control it have failed so far. However, the future looks bright, as we now know the molecular landscape of GBM through the work of The Cancer Genome Atlas (TCGA) program. GBMs exhibit signifi ...
Full textLink to itemCite
Journal ArticleBiomed Res Int · 2017
Chronic pruritus is a difficult condition to treat and is associated with several comorbidities, including insomnia, depression, and decreased quality of life. Treatment for chronic itch includes corticosteroids, antihistamines, and systemic therapies such ...
Full textLink to itemCite
Journal ArticleSci Rep · February 5, 2016
Evidence is mixed for an association between serum insulin-like growth factor-I (IGF-I) levels and postoperative delirium (POD). The current study assessed preoperative serum IGF-I levels as a predictor of incident delirium in non-demented elderly elective ...
Full textLink to itemCite
Journal ArticleJ Neurochem · June 2015
The development of drugs to inhibit glioblastoma (GBM) growth requires reliable pre-clinical models. To date, proteomic level validation of widely used patient-derived glioblastoma xenografts (PDGX) has not been performed. In the present study, we characte ...
Full textLink to itemCite
Journal ArticleCurrent Anesthesiology Reports · March 1, 2015
Delirium is a common problem among the elderly. The incidence of delirium will increase considerably in the coming decades as the proportion of the population over age 65 increases. Given that an FDA-approved drug to treat delirium is not available, effort ...
Full textCite
Journal ArticleSleep Breath · March 2014
INTRODUCTION: Obstructive sleep apnea (OSA) is a medical disorder strongly associated with multiple comorbidities and postoperative complications. Current evidence suggests that OSA disturbs fundamental biochemical processes, leading to low-grade systemic ...
Full textLink to itemCite
Journal ArticleBlood Press · December 2013
In 2009, Blood Pressure featured a debate about whether to treat patients with prehypertension (Kiely et al., Blood Press. 2009;18:300-303; McInnes GT, Blood Press. 2009;18:304-307). Our group supported pharmacotherapy for this condition at that time. Sinc ...
Full textLink to itemCite
Journal ArticleMed Hypotheses · October 2013
Delirium is a common pathologic event in both medical and surgical patients. It is essential to note that patients who develop delirium have worse long term outcomes. The etiology and pathogenesis of delirium are extremely complex and not entirely understo ...
Full textLink to itemCite
Journal ArticleMed Hypotheses · July 2013
Obstructive sleep apnea is common in patients with cardiovascular disease. It is well known that cardiac surgery is a risk factor for delirium. Researchers have shown that obstructive sleep apnea is an independent risk factor for the occurrence of delirium ...
Full textLink to itemCite
Chapter · February 15, 2013
Tachykinins are small peptides, found in both vertebrates and invertebrates, which regulate many physiological processes. They are distributed mainly in the central nervous system, but are also important regulators of contractility in vascular smooth muscl ...
Full textCite
Journal ArticleAnesthesiology · April 2012
BACKGROUND: Postoperative delirium, a common complication in the elderly, can occur following any type of surgery and is associated with increased morbidity and mortality; it may also be associated with subsequent cognitive problems. Effective therapy for ...
Full textLink to itemCite
Journal ArticleJ Neurochem · May 2009
Previous studies have shown that neurokinin 1 receptor (NK1R) occurs naturally in human glioblastomas and its stimulation causes cell proliferation. In the present study we show that stimulation of NK1R in human U373 glioblastoma cells by substance P incre ...
Full textLink to itemCite
Journal ArticleBlood Press · 2009
The 7th Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure provided new guide-lines for the definition and management of hypertension. Notably, a new category-"prehypertension"-was created for intermediate s ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Pharmacol · September 2007
Galphaq-coupled receptors such as alpha1-adrenergic, angiotensin, and endothelin receptors, play key roles in cardiac physiology. These receptors have also been shown to couple to G proteins of the G12 family, including Galpha12 and Galpha13. In this repor ...
Full textLink to itemCite
Journal ArticleCancer Chemother Pharmacol · December 2005
Featured Publication
Substance P receptor (SPR), a G protein-coupled receptor (GPCR), is found in human glioblastomas, and has been implicated in their growth. Consistent with a role for SPR in cell growth, activation of SPR in U373 MG human glioblastoma cells leads to the pho ...
Full textLink to itemCite
Journal ArticleJ Mol Cell Cardiol · February 2005
Featured Publication
Cardiac G alpha(q)-coupled receptors (such as endothelin, angiotensin, and alpha1-adrenergic receptors) mediate cardiac inotropy and chronotropy, as well as the development of hypertrophy. These receptors signal through protein kinase C (PKC), a family of ...
Full textLink to itemCite
Journal ArticleDiabetes · September 2004
In an ongoing investigation of the effects of age on G protein-coupled receptor signaling in human atrial tissue, we have found that the density of atrial muscarinic acetylcholine receptor (mAChR) increases with age but reaches statistical significance onl ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Pharmacol · November 2003
Recently, we demonstrated that beta2AR and several other Galphas-coupled receptors in human atria also couple to Galphai, a G protein that inhibits adenylyl cyclase (AC). The present study was undertaken to determine whether age increases expression of Gal ...
Full textLink to itemCite
Journal ArticleJ Neurochem · February 2003
Substance P receptor (SPR) and its naturally occurring splice-variant, lacking the C-terminal tail, are found in brain and spinal cord. Whether C-terminally truncated SPR desensitizes like full-length SPR is controversial. We used a multivaried approach to ...
Full textLink to itemCite
Journal ArticleAnesthesiology · February 2003
Featured Publication
BACKGROUND: Cardiopulmonary bypass (CPB) has been implicated in the development of organ injury associated with cardiac surgery. At the molecular level, CPB is accompanied by a pronounced proinflammatory response including an increase in plasma interleukin ...
Full textLink to itemCite
Journal ArticleJ Biol Chem · August 23, 2002
Cardiac G protein-coupled receptors that function through stimulatory G protein Galpha(s), such as beta(1)- and beta(2)-adrenergic receptors (beta(1)ARs and beta(2)ARs), play a key role in cardiac contractility. Recent data indicate that several Galpha(s)- ...
Full textLink to itemCite
Journal ArticleFEBS Lett · June 19, 2002
G protein-coupled receptor kinases (GRKs) phosphorylate agonist-occupied G protein-coupled receptors, leading to receptor desensitization. Seven GRKs, designated GRK1 through 7, have been characterized. GRK5 is negatively regulated by protein kinase C. We ...
Full textLink to itemCite
Journal ArticleCirc Res · October 13, 2000
Cardiac G protein-coupled receptors that couple to Galpha(s) and stimulate cAMP formation (eg, beta-adrenergic, histamine, serotonin, and glucagon receptors) play a key role in cardiac inotropy. Recent studies in rodent cardiac myocytes and transfected cel ...
Full textLink to itemCite
Journal ArticleCirculation Research · 2000
Cardiac G protein-coupled receptors that couple to Gα(s) and stimulate cAMP formation (eg, β-adrenergic, histamine, serotonin, and glucagon receptors) play a key role in cardiac inotropy. Recent studies in rodent cardiac myocytes and transfected cells have ...
Cite
Journal ArticleMol Pharmacol · May 1999
Featured Publication
Substance P receptor (SPR), which plays a key role in pain transmission, is known to undergo rapid agonist-dependent desensitization and internalization. The present study shows that human SPR undergoes agonist-dependent phosphorylation in intact cells. Im ...
Link to itemCite
Journal ArticleJ Biol Chem · March 12, 1999
The substance P receptor (SPR) is a G protein-coupled receptor (GPCR) that plays a key role in pain regulation. The SPR desensitizes in the continued presence of agonist, presumably via mechanisms that implicate G protein-coupled receptor kinases (GRKs) an ...
Full textLink to itemCite
Journal ArticleCirculation · November 10, 1998
BACKGROUND: Patients with cardiac valve disease (CVD) frequently have congestive heart failure (CHF) and chronic myocardial beta-adrenergic receptor (beta AR) desensitization. Cardiac surgery requiring cardiopulmonary bypass (CPB) is associated with increa ...
Link to itemCite
Journal ArticleAnesthesiology · September 1998
BACKGROUND: Previously the authors showed that myocardial beta-adrenergic (betaAR) function is reduced after cardiopulmonary bypass (CPB) in a canine model Whether CPB results in similar effects on betaAR function in adult humans is not known. Therefore th ...
Full textLink to itemCite
Journal ArticleFEBS Lett · May 29, 1998
Featured Publication
Substance P receptor (SPR) stably expressed in Chinese hamster ovary (CHO) cells stimulates at least three second messenger systems including phosphoinositide hydrolysis, cyclic AMP (cAMP) formation, and arachidonic acid release. Whether these second messe ...
Full textLink to itemCite
Journal ArticleDNA Seq · March 1998
In spite of their critical importance in myocardial hypertrophy and benign prostatic hyperplasia, nothing is known about mechanisms underlying transcriptional regulation of alpha 1a-adrenergic receptors (alpha 1aARs). Therefore we cloned 6.2 kb of novel se ...
Full textLink to itemCite
Journal ArticleBiochemistry · February 3, 1998
Featured Publication
G protein-coupled receptor kinases (GRKs) phosphorylate agonist-occupied G protein-coupled receptors (GPCRs), resulting in GPCR desensitization. GRK2 is one of the better studied of the six known GRKs and phosphorylates several GPCRs. In a previous study, ...
Full textLink to itemCite
Journal ArticleJ Recept Signal Transduct Res · January 1998
To identify the G proteins involved in the function of human substance P receptor (hSPR), the receptor was expressed in Sf9 cells using the baculovirus expression system. Maximal hSPR expression was up to 65 pmol/mg membrane protein. The following data ind ...
Full textLink to itemCite
Journal ArticleFASEB Journal · December 1, 1997
We expressed the human substance P receptor (hSPR) in Sf9 cells at high levels (>50 pmol/mg membrane protein) and examined its ability to serve as GRK2 substrate in intact membranes. The hSPR in Sf9 membranes was phosphorylated by purified GRK2 in agonist- ...
Cite
Journal ArticleJ Biol Chem · November 7, 1997
We recently cloned cDNAs encoding three subtypes of human alpha1-adrenergic receptors (alpha1ARs), alpha1a, alpha1b, and alpha1d (Schwinn, D. A., Johnston, G. L., Page, S. O., Mosley, M. J., Wilson, K. H., Worman, N. P., Campbell, S., Fidock, M. D., Furnes ...
Full textLink to itemCite
Journal ArticleBiochim Biophys Acta · June 11, 1996
G(alpha q), a member of the Gq family of heterotrimeric G proteins, transduces signals from several G protein-coupled receptors that stimulate membrane phosphoinositide hydrolysis. In order to further define the role of G(alpha q) in the function of G prot ...
Full textLink to itemCite
Journal ArticleProtein Expr Purif · December 1995
To obtain large quantities of pure human beta 2-adrenergic receptor (beta 2-AR) needed for structural studies, an efficient method for beta 2-AR purification was developed using a recombinant receptor with an eight amino acid epitope at its C-terminus. Thi ...
Full textLink to itemCite
Journal ArticleCirc Res · May 1995
The cardiac muscarinic potassium channel (IK.ACh) is activated by a G protein upon receptor stimulation with acetylcholine. The G protein subunit responsible for activation (G alpha versus G beta gamma) has been disputed. We used G beta gamma inhibitors de ...
Full textLink to itemCite
Journal ArticleJ Biol Chem · January 28, 1994
An aromatic residue, tyrosine 326 in the prototypical human beta 2-adrenergic receptor, exists in a highly conserved sequence motif in virtually all members of the G protein-coupled receptor family. The potential role of this conserved aromatic amino acid ...
Link to itemCite
Journal ArticleMethods · January 1, 1994
Most members of the G-protein-coupled receptor (GPCR) superfamily, which includes several hundred receptors, exhibit agonist-induced desensitization. Studies with rhodopsin and β2-adrenergic receptors indicate that a key biochemical event underlying the pr ...
Full textCite
Journal ArticleBiochim Biophys Acta · October 7, 1993
Treatment of smooth-muscle cells with R-phenylisopropyladenosine (R-PIA) leads to a loss of A1 adenosine receptor (A1AR)-mediated inhibition of adenylate cyclase, a decrease in receptor number and an increase in receptor phosphorylation. In this study, the ...
Full textLink to itemCite
Journal ArticleJ Biol Chem · May 5, 1993
Featured Publication
The agonist-occupied forms of several G-protein-coupled receptors that modulate the activity of adenylycyclase via Gs (e.g. beta 2-adrenergic) or Gi (e.g. alpha 2-adrenergic and cardiac muscarinic) are phosphorylated by beta-adrenergic receptor kinases (be ...
Link to itemCite
Journal ArticleJ Biol Chem · September 5, 1992
Homologous or agonist-specific desensitization of beta 2-adrenergic receptors (beta 2AR) is mediated by the beta-adrenergic receptor kinase (beta ARK) which specifically phosphorylates the agonist-occupied form of the receptor. However, the capacity of bet ...
Link to itemCite
Journal ArticleJournal of Biological Chemistry · September 5, 1992
Homologous or agonist-specific desensitization of β2-adrenergic receptors (β2AR) is mediated by the β-adrenergic receptor kinase (βARK) which specifically phosphorylates the agonist-occupied form of the receptor. However, the capacity of βARK-phosphorylate ...
Cite
Journal ArticleScience · August 28, 1992
The rate and extent of the agonist-dependent phosphorylation of beta 2-adrenergic receptors and rhodopsin by beta-adrenergic receptor kinase (beta ARK) are markedly enhanced on addition of G protein beta gamma subunits. With a model peptide substrate it wa ...
Full textLink to itemCite
Journal ArticleBiochim Biophys Acta · March 16, 1992
Featured Publication
To examine the role of the ligand binding domain of epidermal growth factor receptor in its dimerization, we studied the dimerization of a truncated form of the receptor that resembles v-erbB in that it lacks a ligand binding domain. Receptor dimerization ...
Full textLink to itemCite
Journal ArticleProc Natl Acad Sci U S A · June 1990
We have investigated human gliomas that amplify and rearrange the epidermal growth factor receptor gene, with generation of an in-frame deletion mutation of 802 nucleotides in the external domain. This in-frame deletion mutation generates a local amino aci ...
Full textLink to itemCite
Journal ArticleBiochemistry · May 30, 1989
Previous studies have demonstrated that muscarinic cholinergic receptors (mAChR) become markedly phosphorylated when intact cardiac cells are stimulated with a muscarinic agonist. This process appears to be related to the process of receptor desensitizatio ...
Full textLink to itemCite
Journal ArticleMol Pharmacol · May 1989
Featured Publication
Recently we showed that the chick heart muscarinic acetylcholine receptor is a phosphoprotein in intact cells and that treatment with agonists results in a striking increase in receptor phosphorylation [J. Biol. Chem. 261:12429-12432 (1986)]. Furthermore, ...
Link to itemCite
Journal ArticleJ Pharmacol Exp Ther · March 1988
[125I]N6-(p-aminobenzyl)adenosine and [125I]N6-(p-azidobenzyl)adenosine, which are potent agonists at A1 (Ri) adenosine receptors, have been used to characterize the adenosine receptor in membranes prepared from newborn chick heart. Scatchard analyses of [ ...
Link to itemCite
Journal ArticleJ Biol Chem · December 5, 1987
Featured Publication
We have determined whether the process of agonist-mediated phosphorylation of the muscarinic receptor correlates with the process of muscarinic receptor desensitization in chick cardiac tissue. Exposure of ventricular slices to the agonist carbachol under ...
Link to itemCite
Journal ArticleJ Med Chem · May 1987
A number of N6-phenyladenosines with various substitutions on the phenyl ring have been synthesized and tested for their affinities toward brain A1 and A2 adenosine receptors. Compounds with meta substituents, such as (m-hydroxy- and m-iodophenyl)adenosine ...
Full textLink to itemCite
Journal ArticleJournal of Medicinal Chemistry · 1987
A number of N6-phenyladenosines with various substitutions on the phenyl ring have been synthesized and tested for their affinities toward brain A1 and A2 adenosine receptors. Compounds with meta substituents, such as (m-hydroxy-and m-iodophenyl)adenosine, ...
Cite
Journal ArticleJ Biol Chem · September 25, 1986
Featured Publication
We have tested the possibility that regulation of cardiac muscarinic receptor function may involve receptor phosphorylation. Chick heart muscarinic receptors were purified from relatively small amounts of tissue to near homogeneity using a three-step chrom ...
Link to itemCite
Journal ArticleBiochem Biophys Res Commun · August 30, 1985
N6(L-phenylisopropyl)adenosine (L-PIA) and N6(3-iodo-4-azido benzyl)-adenosine (IAzBA) inhibit the adenylate cyclase activity in synaptic membranes of chick cerebellum via Ri adenosine receptors. [3H]L-PIA and [125I]AzBA bind to these membranes with Kd val ...
Full textLink to itemCite
Journal ArticleJ Med Chem · March 1978
A number of N,N-dialkyl-3-phenylpropyn-2-amines 7 have been prepared and tested for their biological action. Certain analogues show tryptamine-like behavior effects in mice. The tryptamine-like activity of these compounds appears to be controlled by their ...
Full textLink to itemCite